Gene · 3376
Papers2,904
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,904
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| chi-miR-487b-3p Inhibits Goat Myoblast Proliferation and Differentiation by Targeting IRS1 through the IRS1/PI3K/Akt Signaling Pathway. | Int J Mol Sci | 2021 | 35008541 | PubTator, text mining | PubMed |
| Role of circular RNAs in gastrointestinal tumors and drug resistance. | World J Clin Cases | 2021 | 35004973 | PubTator, text mining | PubMed |
| Mutational Characterization of Colorectal Cancer from Korean Patients with Targeted Sequencing. | J Cancer | 2021 | 35003350 | PubTator, text mining | PubMed |
| Approaches to Decrease Hyperglycemia by Targeting Impaired Hepatic Glucose Homeostasis Using Medicinal Plants. | Front Pharmacol | 2021 | 35002743 | PubTator, text mining | PubMed |
| Insulin receptor cleavage induced by estrogen impairs insulin signaling. | BMJ Open Diabetes Res Care | 2021 | 34969688 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Myoferlin in Human Pancreatic Cancer via Bioinformatics. | Biomed Res Int | 2021 | 34957301 | PubTator, text mining | PubMed |
| Exosomal circRNAs: Emerging Players in Tumor Metastasis. | Front Cell Dev Biol | 2021 | 34957113 | PubTator, text mining | PubMed |
| Recent Advances in the Inhibition of the IL-4 Cytokine Pathway for the Treatment of Allergen-Induced Asthma. | Int J Mol Sci | 2021 | 34948449 | PubTator, text mining | PubMed |
| The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases. | J Pers Med | 2021 | 34945845 | PubTator, text mining | PubMed |
| The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease. | Biomedicines | 2021 | 34944668 | PubTator, text mining | PubMed |
| Pathways in Skeletal Muscle: Protein Signaling and Insulin Sensitivity after Exercise Training and Weight Loss Interventions in Middle-Aged and Older Adults. | Cells | 2021 | 34943997 | PubTator, text mining | PubMed |
| Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies. | Diagnostics (Basel) | 2021 | 34943483 | PubTator, text mining | PubMed |
Based on voxel-based morphological analysis to investigate the effect of acupuncture-rehabilitation therapy on hippocampal volume and its neuroprotective mechanism in patients with vascular cognitive impairment with type 2 diabetes mellitus: A study protocol. | Medicine (Baltimore) | 2021 | 34941076 | PubTator, text mining | PubMed |
| Which Role Plays 2-Hydroxybutyric Acid on Insulin Resistance? | Metabolites | 2021 | 34940595 | PubTator, text mining | PubMed |
| Clinical Characteristics and Management of Patients With Clinical Amyopathic Dermatomyositis: A Retrospective Study of 64 Patients at a Tertiary Dermatology Department. | Front Med (Lausanne) | 2021 | 34926528 | PubTator, text mining | PubMed |
| Potential Clinical Applications of Exosomal Circular RNAs: More than Diagnosis. | Front Mol Biosci | 2021 | 34901159 | PubTator, text mining | PubMed |
| Genes and Pathways Associated with Skeletal Sagittal Malocclusions: A Systematic Review. | Int J Mol Sci | 2021 | 34884839 | PubTator, text mining | PubMed |
| A Novel PTP1B Inhibitor-Phosphate of Polymannuronic Acid Ameliorates Insulin Resistance by Regulating IRS-1/Akt Signaling. | Int J Mol Sci | 2021 | 34884501 | PubTator, text mining | PubMed |
| Epigenetic Modifications and Therapy in Uveitis. | Front Cell Dev Biol | 2021 | 34869347 | PubTator, text mining | PubMed |
| The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease. | Front Pharmacol | 2021 | 34867414 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3376/papers?page=43